Breast Tumor Heterogeneity Quantification using Ultrasound-based Shearwave ELastography - NI

Indian Institute of Technology Hyderabad0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: B- Imaging

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: B- Imaging
Sponsor: Indian Institute of Technology Hyderabad
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Investigators

Sponsor

Indian Institute of Technology Hyderabad

Eligibility Criteria

Inclusion Criteria

•1\. Patients consenting to participate in the study
•2\. Age 18 or above
•3\. Primary breast tumor (with or without metastases)
•4\. Adequate clinical parameters for breast tumor ultrasound imaging
•5\. Ability to maintain a supine position during the study

Exclusion Criteria

•1\. Pregnant or currently lactating female participants
•2\. Significant renal or hepatic impairment
•3\. Uncontrolled illness or medical conditions that hinder ultrasound imaging
•4\. Skin ulceration or issues affecting the proper placement of ultrasound transducer
•5\. Inability to tolerate required position or procedure during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

Detection of intratumoral heterogeneity of breast cancer by multiparametric imaging using 18F-FDG-PET/MRTprimary breasttumorC50Malignant neoplasm of breast

DRKS00013891niversitätsklinikum Tübingen, Radiologiesche Klinik, Interv. u. Diagnostische Radiologie61

Not yet recruiting

Phase 1/2

Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.

2024-512152-38-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela100

Recruiting

Not Applicable

Tumor differentiation in breast carcinomas with a novel physical methodC50Malignant neoplasm of breast

DRKS00012767Department für Frauengesundheit150

Active, not recruiting

Phase 1

Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]

EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130

Recruiting

Not Applicable

Early detection of Hereditary Breast Cancer by Monitoring MicroRNA expression in Nipple Aspirate Fluid

NL-OMON24687Vrienden UMC Utrecht620